For POET's detector (formerly known as Denselight's Glucose Monitor), maybe the recent financing is towards POET taking over the RNVA listing on the Nasdaq. That stock has traded nearly 8 million shares today and is up 30%. Perhaps, we might be wedging in and the new CFO is already familiar with that company. It is a stretch, but after close today it could come about as a possible takeover or merger. The low financing might have been done to get the approval of their BOD and help shore up assets for Nasdaq requirements. I am only suggesting this possibility because Denselight brought the glucose monitor to the table and it might just prove to be a catalyst for the company overall that could not be passed up.
We'll see ... you never know. We were surprised by a couple of quick acquisitions before. Please note that this theory is 100% speculative reasoning.
Monolithic
